Addition of chemotherapy to ADT improves bPFS in prostate cancer
“Our clinical trial is the first to show a longer time to biochemical recurrence with chemotherapy plus standard hormone therapy for patients with locally advanced, high-risk prostate cancer,” says Jiahua Pan, MD.